Catherine Berry
University of Glasgow
H-index: 35
Europe-United Kingdom
Top articles of Catherine Berry
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Pregnancy Outcomes in Multidrug-Resistant Tuberculosis in TB-PRACTECAL | Clinical Infectious Diseases | Tim Crocker-Buque Nathalie Lachenal Cindy Narasimooloo Tleubergen Abdrasuliev Nargiza Parpieva | 2024/2/29 |
Short oral regimens for pulmonary rifampicin-resistant tuberculosis (TB-PRACTECAL): an open-label, randomised, controlled, phase 2B-3, multi-arm, multicentre, non-inferiority trial | The Lancet Respiratory Medicine | Bern-Thomas Nyang'wa Catherine Berry Emil Kazounis Ilaria Motta Nargiza Parpieva | 2024/2/1 |
Nine-month, all-oral regimens for rifampin-resistant tuberculosis | medRxiv | Lorenzo Guglielmetti Uzma Khan Gustavo E Velasquez Maelenn Gouillou Amanzhan Abubakirov | 2024 |
Vaccines against sars-cov-2 infections | 2024/1/18 | ||
The Safety and Tolerability of Linezolid in Novel Short-Course Regimens Containing Bedaquiline, Pretomanid, and Linezolid to Treat Rifampicin-Resistant Tuberculosis: An … | Clinical infectious diseases | Tasnim Hasan Ellie Medcalf Bern-Thomas Nyang'wa Erica Egizi Catherine Berry | 2024/3/15 |
Prevalence of physical frailty, including risk factors, up to 1 year after hospitalisation for COVID-19 in the UK: a multicentre, longitudinal cohort study | EClinicalMedicine | Hamish JC McAuley Rachael A Evans Charlotte E Bolton Christopher E Brightling James D Chalmers | 2023/3/1 |
Long COVID research: an update from the PHOSP-COVID Scientific Summit | The Lancet Respiratory Medicine | Christopher E Brightling Rachael A Evans Amisha Singapuri Nikki Smith Louise V Wain | 2023/11/1 |
Effects of sleep disturbance on dyspnoea and impaired lung function following hospital admission due to COVID-19 in the UK: a prospective multicentre cohort study | The Lancet Respiratory Medicine | Callum Jackson Iain D Stewart Tatiana Plekhanova Peter S Cunningham Andrew L Hazel | 2023/8/1 |
Determinants of recovery from post-COVID-19 dyspnoea: analysis of UK prospective cohorts of hospitalised COVID-19 patients and community-based controls | The Lancet Regional Health–Europe | Bang Zheng Giulia Vivaldi Luke Daines Olivia C Leavy Matthew Richardson | 2023/6/1 |
Beta-containing bivalent SARS-CoV-2 protein vaccine elicits durable broad neutralization in macaques and protection in hamsters | Communications Medicine | Catherine Berry Vincent Pavot Natalie G Anosova Michael Kishko Lu Li | 2023/5/26 |
Standards for clinical trials for treating TB | The International Journal of Tuberculosis and Lung Disease | P du Cros J Greig J-WC Alffenaar GB Cross C Cousins | 2023/12/1 |
Beta variant COVID-19 protein booster vaccine elicits durable cross-neutralization against SARS-CoV-2 variants in non-human primates | Nature Communications | Vincent Pavot Catherine Berry Michael Kishko Natalie G Anosova Lu Li | 2023/3/10 |
Overcoming BCR:: ABL1 dependent and independent survival mechanisms in chronic myeloid leukaemia using a multi-kinase targeting approach | Cell Communication and Signaling | Caroline Busch Theresa Mulholland Michele Zagnoni Matthew Dalby Catherine Berry | 2023/11/29 |
STUDY PROTOCOL | Katelyn M Sileo Christine Muhumuza Samuel Sekamatte Haruna Lule Rhoda K Wanyenze | 2022 | |
A Beta-containing bivalent SARS-CoV-2 spike protein vaccine candidate with AS03 elicits durable and broad neutralization of variants including Omicron in macaques and confers … | Catherine Berry Vincent Pavot Natalie Anosova Michael Kishko Dean Huang | 2022/9/2 | |
Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study | The Lancet Respiratory Medicine | Rachael Andrea Evans Olivia C Leavy Matthew Richardson Omer Elneima Hamish JC McAuley | 2022/8/1 |
A 24-week, all-oral regimen for rifampin-resistant tuberculosis | New England Journal of Medicine | Bern-Thomas Nyang’wa Catherine Berry Emil Kazounis Ilaria Motta Nargiza Parpieva | 2022/12/22 |
TB-PRACTECAL: study protocol for a randomised, controlled, open-label, phase II–III trial to evaluate the safety and efficacy of regimens containing bedaquiline and pretomanid … | Trials | Catherine Berry Philipp du Cros Katherine Fielding Suzanne Gajewski Emil Kazounis | 2022/6/13 |
Extracellular vesicle cargo metabolome changes in response to the mesenchymal stromal cell microenvironment and influences cell quiescence and activation in a human breast … | bioRxiv | Sara Bartlome Yinbo Xiao Ewan Ross Matthew John Dalby Catherine Cecilia Berry | 2022/12/16 |
Protein-based SARS-CoV-2 spike vaccine booster increases cross-neutralization against SARS-CoV-2 variants of concern in non-human primates | Nature communications | Vincent Pavot Catherine Berry Michael Kishko Natalie G Anosova Dean Huang | 2022/3/31 |
